ESC 2024 - Scott Solomon shares the results of the FINEARTS-HF trial, in which the efficacy of finerenone was examined in patients with HFmrEF/HFpEF. He says: "This offers clinicians a new option for the treatment of these patients with an enormous unmet need."
Register
We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?
In patients with HFmrEF/HFpEF, finerenone reduces composite of CV death or total HF events
Restart
Resume
Transcript
In patients with HFmrEF/HFpEF, finerenone reduces composite of CV death or total HF events
closeShare this program on:
Choose a format
Media formats available:
Completing the pre-test is required to access this content.
Completing the pre-survey is required to view this content.
Ready to Claim Your Credits?
You have attempts to pass this post-test. Take your time and review carefully before submitting.
Good luck!
Details
Presenters
Comments
Overview
Educational information
This video was recorded during the ESC Congress 2024 in London, UK.
Faculty
Scott D. Solomon, MD is the Edward D. Frohlich Distinguished Chair, Professor of Medicine at Harvard Medical School and Senior Physician at Brigham and Women’s Hospital in Boston, MA, US. He directs the Cardiac Imaging Core Laboratory and the Clinical Trials Endpoints Center at Brigham and Women’s Hospital.
Disclaimer
This recording was developed under auspices of PACE-CME. Views expressed in the recording are those of the presenter and do not necessarily reflect the views of PACE-CME.
Read our summary of FINEARTS-HF
Release date: 1 September 2024
Recommended
Details
Presenters
Comments
Overview
ESC 2024 - Scott Solomon shares the results of the FINEARTS-HF trial, in which the efficacy of finerenone was examined in patients with HFmrEF/HFpEF. He says: "This offers clinicians a new option for the treatment of these patients with an enormous unmet need."
Educational information
This video was recorded during the ESC Congress 2024 in London, UK.
Faculty
Scott D. Solomon, MD is the Edward D. Frohlich Distinguished Chair, Professor of Medicine at Harvard Medical School and Senior Physician at Brigham and Women’s Hospital in Boston, MA, US. He directs the Cardiac Imaging Core Laboratory and the Clinical Trials Endpoints Center at Brigham and Women’s Hospital.
Disclaimer
This recording was developed under auspices of PACE-CME. Views expressed in the recording are those of the presenter and do not necessarily reflect the views of PACE-CME.
Read our summary of FINEARTS-HF
Release date: 1 September 2024